Bharat BioTech Phase 3 trail
Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity
One adverse event was reported but was unrelated to the vaccine
Covaxin jabs possibly part of Bharat Biotech's Phase 3 trial
When Covaxin's “emergency use” was approved by the government, it was done under “clinical trial mode”
1 of 1